Source map — Experimental Lilly combination drug tops Zepbound in weight-loss trial
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| The Guardian | news | 60% |
| CNBC | news | 60% |
| Reuters | news | 60% |
| USA Today | news | 60% |
| Fierce Biotech | news | 60% |
| arstechnica.com | news | 50% |
| www.biopharmadive.com | news | 50% |
| www.medicaldaily.com | news | 50% |
| finance.yahoo.com | news | 50% |
| www.cnbc.com | news | 50% |
| www.gurufocus.com | news | 50% |
| stockanalysis.com | news | 50% |